MEMAC Learners’ Questionnaire 2nd Middle East Master Class in HematologyJanuary 10 – 12, 2025 – Raffles Hotel, Dubai – UAEwww.memachematology.com Step 1 of 2 50% Dear 2025 MEMAC Participant, In order to receive your EBAH-CME accreditation points for attending the 2nd Middle East Master Class in Hematology, January 10-12, 2025, Dubai, UAE, please complete the following learner’s questionnaire. Should you have any questions, please contact: [email protected], or [email protected]. Many thanks, The IACH Secretariat on behalf of the MEMAC Organizers 1. This event has fulfilled my educational goals and my expected learning outcomes 5 – Agree 4 3 – Neutral 2 1 – Disagree 2. I have learned information at this event that will help me to improve my practice 5 – Agree 4 3 – Neutral 2 1 – Disagree 3. The education provided at this event consistently was very good or excellent 5 – Agree 4 3 – Neutral 2 1 – Disagree 4. There was sufficient time for discussions, questions & answers and learner engagement 5 – Agree 4 3 – Neutral 2 1 – Disagree 5. The information presented consistently was supported by a valid scientific evidence base 5 – Agree 4 3 – Neutral 2 1 – Disagree 6. The speakers consistently were very good or excellent 5 – Agree 4 3 – Neutral 2 1 – Disagree 7. There was no bias in any of the programmed educational events 5 – Agree 4 3 – Neutral 2 1 – Disagree Comments:PROGRAM EVALUATION:Session 1: State-of-the-Art Diagnosis & Therapy in Myeloid MalignanciesFriday – January 10th 09:30-10:40 Did you attend this session? Yes No Session 2: State-of-the-Art Diagnosis and Therapy in ALLFriday – January 10th 11:25-12:15 Did you attend this session? Yes No Session 3: State-of-the-Art Diagnosis and Therapy in Chronic LeukemiasFriday – January 10th 15:45-16:35 Did you attend this session? Yes No Session 4: Plenary LectureFriday – January 10th 17:20-18:30 Did you attend this session? Yes No Session 5: Opening LectureFriday – January 10th 19:00-19:50 Did you attend this session? Yes No Session 6: State-of-the-Art Diagnosis & Therapy in Bome Marrow Failures & Precursor ConditionsSaturday – January 11th 09:15-10:05 Did you attend this session? Yes No Session 7: State-of-the-Art Diagnosis in Therapy in LymphomaSaturday – January 11th 11:20-12:10 Did you attend this session? Yes No Session 8: State-of-the-Art Diagnosis & Therapy in Multiple MyelomaSaturday – January 11th 13:55-15:05 Did you attend this session? Yes No Session 9: Plenary LectureSaturday – January 11th 16:20-16:55 Did you attend this session? Yes No Session 10: How I Use MRD in Blood CancersSunday – January 12th 09:15-10:05 Did you attend this session? Yes No Session 11: Novel Therapies in HematologySunday – January 12th 11:20-12:15 Did you attend this session? Yes No Comments: Personal InformationConsent(Required) I hereby confirm the completed form is correct and that I actively attended the 2025 MEMAC course scientific sessions as marked herein:(Required)Date(Required) MM slash DD slash YYYY SignatureTitle(Required)First name(Required)Last name(Required)Country of origin(Required)Please selectAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland IslandsEBAH Member number(Required)Email address(Required)